4-(2-氯乙基)-1,2-二甲氧基苯 | 27160-08-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(2-氯乙基)-1,2-二甲氧基苯
• 中文别名: 11&amp#x3B2,17,21-三羟基孕-4-烯-3,20-二酮21-特戊酰茚二酮酸酯
• 英文名称: 2-(3,4-dimethoxyphenyl)-ethylchloride
• 英文别名: 4-(2-chloroethyl)-1,2-dimethoxybenzene
• CAS: 27160-08-3
• 化学式: C₁₀H₁₃ClO₂
• 分子量: 200.665
• InChiKey: VZGITQAWSRBJPP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  4-(2-氯乙基)-1,2-二甲氧基苯 在 氢氧化钾 、 sodium iodide 作用下， 以 甲醇 、 乙醇 、 水 为溶剂， 生成 3,4-二甲氧基苯丙酸
  参考文献：
  名称：

  Studies in the Tetrahydronaphthalene Series: Synthesis of 1-Methyl-1-ethyl-2-n-propyl-7,8-dimethoxy-1,2,3,4-tetrahydronaphthalene

  摘要：

  DOI：

  10.1021/jo01065a014
• 作为产物：
  描述：

  3,4-二甲氧基苯乙酸甲酯 在 lithium aluminium tetrahydride 、 氯化亚砜 作用下， 以 乙醚 为溶剂， 生成 4-(2-氯乙基)-1,2-二甲氧基苯
  参考文献：
  名称：

  Sulfur Heterocycles from the Ring Closure of Bisarylalkyl Disulfides^1,2

  摘要：

  DOI：

  10.1021/jo01031a064

文献信息

• Design, Synthesis, Structure−Activity Relationships, and Biological Characterization of Novel Arylalkoxyphenylalkylamine σ Ligands as Potential Antipsychotic Drugs
  作者：Atsuro Nakazato、Kohmei Ohta、Yoshinori Sekiguchi、Shigeru Okuyama、Shigeyuki Chaki、Yutaka Kawashima、Katsuo Hatayama

  DOI：10.1021/jm980212v

  日期：1999.3.1

  sigma Receptor antagonists may be effective antipsychotic drugs that do not induce motor side effects caused by ingestion of classical drugs such as haloperidol. We obtained evidence that 1-(2-dipropylaminoethyl)-4-methoxy-6H-dibenzo[b,d]pyran hydrochloride 2a had selective affinity for sigma receptor over dopamine D2 receptor. This compound was designed to eliminate two bonds of apomorphine 1 to produce

  sigma受体拮抗剂可能是有效的抗精神病药物，不会引起因摄入氟哌啶醇等经典药物而引起的运动副作用。我们获得的证据表明，1-（2-二丙基氨基乙基）-4-甲氧基-6H-二苯并[b，d]吡喃盐酸盐2a对sigma受体的选择性亲和力高于多巴胺D2受体。设计该化合物可消除阿扑吗啡1的两个键，从而为氮原子产生结构柔性，并通过-CH2O-键桥接两个苯环，以维持平面结构。根据证据，设计了N，N-二丙基-2-（4-甲氧基-3-苄氧基苯基）乙胺盐酸盐10b。由于化合物10b消除了6H-二苯并[b，d]吡喃衍生物2a的联苯键，因此与化合物2a相比，它可能从阿扑吗啡1的刚性结构中释放出来。化合物10b的化学修饰导致人们发现，N，N-二丙基-2- [4-甲氧基-3-（2-苯基乙氧基）苯基]乙胺盐酸盐10g（NE-100）是芳基烷氧基苯基烷基胺衍生物3中最好的化合物，口服该药物对sigma受体具有很高的选择性亲和力，
• 2-Imino-imidazolidine derivatives
  申请人：Hoffman-La Roche Inc.

  公开号：US04244957A1

  公开（公告）日：1981-01-13

  2-Imino-imidazolidine derivatives of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as hereinafter set forth, and pharmaceutically acceptable acid addition salts thereof, are described. The 2-imino-imidazolidine derivatives are useful in the treatment of hypertension.

  描述了公式##STR1##中R.sup.1、R.sup.2、R.sup.3和R.sup.4如下所述的2-亚胺-咪唑烷衍生物，以及其药学上可接受的酸盐。这些2-亚胺-咪唑烷衍生物在治疗高血压方面是有用的。
• Pyridazine compounds and compositions containing the same
  申请人：Kowa Co., Ltd.

  公开号：US06348468B1

  公开（公告）日：2002-02-19

  This invention relates to pyridazine derivatives represented by the formula (1): wherein R1 represents a (substituted) aryl group, R2 represents a phenyl group substituted at 4-position by a lower alkoxyl group or a lower alkylthio group, R3 represents a lower alkoxyl group, a halogenated lower alkyl group, a lower cycloalkyl group, a (subsituted) aryl group, a (substituted) aryloxy group, a (substituted) nitrogen-containing heterocyclic ring residue, a (substituted) aminocarbonyl group or a lower alkylcarbonyl group, A represents a single bond, a lower alkylene group or a lower alkenylene group, X represents O or S, and the dashed line indicates that the carbon-carbon bond between the 4-position and the 5-position is a single bond or a double bond, or salts thereof; and also to medicines containing them as effective ingredients. These compounds have excellent inhibitory activity against interleukin-1&bgr; production, and are useful as preventives and therapeutics for immune system diseases, inflammatory diseases, ischemic diseases and the like.

  这项发明涉及由式（1）表示的吡啶嗪衍生物： 其中R1代表（取代的）芳基，R2代表在4位被低烷氧基或低烷硫基取代的苯基，R3代表低烷氧基、卤代低烷基、低环烷基、（取代的）芳基、（取代的）芳氧基、（取代的）含氮杂环环残基、（取代的）氨基羰基或低烷基羰基，A代表单键、低烷基烯基或低烷烯基，X代表O或S，虚线表示4位和5位之间的碳-碳键为单键或双键，或其盐；以及含有它们作为有效成分的药物。这些化合物对白细胞介素-1β的产生具有出色的抑制活性，并可用作免疫系统疾病、炎症性疾病、缺血性疾病等的预防和治疗药物。
• Benzazepine derivatives, their pharmaceutical compositions and method of
  申请人：Dr. Karl Thomae Gesellschaft mit beschrankter Haftung

  公开号：US04490369A1

  公开（公告）日：1984-12-25

  Compounds of the formula ##STR1## wherein A is --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, --NH--CO--, --CH.sub.2 --CO-- or ##STR2## where R.sub.7 is alkyl of 1 to 3 carbon atoms, and B is methylene, carbonyl or thiocarbonyl, or A is --CO--CO--, --N.dbd.CH--, ##STR3## where R.sub.8 is hydrogen or alkyl of 1 to 3 carbon atoms substituted by a phenyl, methoxyphenyl or dimethoxyphenyl, and B is methylene; E is n-alkylene of 2 to 4 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, 2-hydroxy-n-propylene, 2-hydroxy-n-butylene or 3-hydroxy-n-butylene; G is n-alkylene of 1 to 5 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, wherein one methylene group of an n-alkylene of 2 to 5 carbon atoms can be replaced by a carbonyl group, with the proviso that B represents a methylene or carbonyl group, or methylene-n-hydroxy-alkylene of 1 to 4 carbon atoms, where the methylene group is attached to the nitrogen atom; and R.sub.1 to R.sub.5 are simple substituents of various types; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

  式为##STR1##的化合物，其中A为--CH.sub.2 --CH.sub.2 --，--CH.dbd.CH--，--NH--CO--，--CH.sub.2 --CO--或##STR2##，其中R.sub.7为1至3个碳原子的烷基，B为亚甲基，羰基或硫代羰基，或A为--CO--CO--，--N.dbd.CH--，##STR3##其中R.sub.8为氢或1至3个碳原子的烷基，其被苯基，甲氧基苯基或二甲氧基苯基取代，B为亚甲基；E为2至4个碳原子的n-烷基，可选择地被1至3个碳原子的烷基，2-羟基-n-丙烯基，2-羟基-n-丁烯基或3-羟基-n-丁烯基取代；G为1至5个碳原子的n-烷基，可选择地被1至3个碳原子的烷基取代，其中2至5个碳原子的n-烷基的一个亚甲基可以被羰基取代，条件是B代表亚甲基或羰基，或者为1至4个碳原子的亚甲基-n-羟基-烷基，其中亚甲基与氮原子相连；R.sub.1至R.sub.5为各种类型的简单取代基；以及其非毒性、药理学上可接受的酸盐。这些化合物及其盐可用作心动过缓药。
• Synthesis of the Heterocyclic Compounds by Pschorr Cyclization. II. Syntheses of Substituted-6, 7-dihydrobenzo [a] quinolizinium Salts.
  作者：Sanya Akaboshi、Toshio Kato、Akisuke Saiga

  DOI：10.1248/cpb.11.1446

  日期：——

  The Pschorr reaction of 1- (2-amino-4, 5-methylenedioxyphenethyl) pyridinium (Va'), 1- (2-amino-4, 5-dimethoxyphenethyl) pyridinium (Vb) and 1- (2-amino-4, 5-dimethoxyphenethyl) picolinium (Vc) salts was carried out and the corresponding cyclized product was obtained respectively. 2-Amino-1- (3, 4-methylenedioxyphenethyl) pyridinium salt was prepared and its Pschorr reaction was investigated.

  1-(2-氨基-4,5-亚甲二氧基苯乙基)吡啶鎓(Va')、1-(2-氨基-4,5-二甲氧基苯乙基)吡啶鎓(Vb)和1-(2-氨基-4,进行5-二甲氧基苯乙基)吡啶鎓(Vc)盐的合成，分别得到相应的环化产物。制备了2-氨基-1-(3,4-亚甲二氧基苯乙基)吡啶鎓盐并研究了其Pschorr反应。